LAVA Therapeutics N.V. (LVTX) Tops Q1 EPS by 29c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q1 EPS of ($0.02), $0.29 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $6.99 million.

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UBS Upgrades Apollo Tyres (APTY:IN) to Buy
• Investing.com’s stocks of the week